Review
Open access
Jul 2026
In vivo CRISPR editing for cancer immunotherapy
This review summarizes recent progress in applying CRISPR systems in vivo for cancer immunotherapy, focusing on approaches that target cancer cells and the tumor microenvironment, as well as those that directly engineer immune cell populations themselves.
Cole W. Christopher, Xiaoyu Zhou
· Frontiers in Immunology · 0 citations